192 related articles for article (PubMed ID: 26179474)
1. Coumarins as Potential Inhibitors of DNA Polymerases and Reverse Transcriptases. Searching New Antiretroviral and Antitumoral Drugs.
Garro HA; Pungitore CR
Curr Drug Discov Technol; 2015; 12(2):66-79. PubMed ID: 26179474
[TBL] [Abstract][Full Text] [Related]
2. DNA Related Enzymes as Molecular Targets for Antiviral and Antitumoral Chemotherapy. A Natural Overview of the Current Perspectives.
Garro HA; Pungitore CR
Curr Drug Targets; 2019; 20(1):70-80. PubMed ID: 29697027
[TBL] [Abstract][Full Text] [Related]
3. Coumarins as inhibitors of HIV reverse transcriptase.
Kostova I
Curr HIV Res; 2006 Jul; 4(3):347-63. PubMed ID: 16842086
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of human immunodeficiency virus type 1 reverse transcriptase mediated by soulattrolide, a coumarin isolated from the latex of calophyllum teysmannii.
Pengsuparp T; Serit M; Hughes SH; Soejarto DD; Pezzuto JM
J Nat Prod; 1996 Sep; 59(9):839-42. PubMed ID: 8864237
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives.
Huang L; Yuan X; Yu D; Lee KH; Chen CH
Virology; 2005 Feb; 332(2):623-8. PubMed ID: 15680427
[TBL] [Abstract][Full Text] [Related]
6. Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.
Balzarini J; Ford A; Maguire NM; John J; Das K; Arnold E; Dehaen W; Maguire A
Future Med Chem; 2019 Jan; 11(2):137-154. PubMed ID: 30648904
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
Dharmaratne HR; Tan GT; Marasinghe GP; Pezzuto JM
Planta Med; 2002 Jan; 68(1):86-7. PubMed ID: 11842340
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.
Clark DN; Hu J
Antiviral Res; 2015 Nov; 123():132-7. PubMed ID: 26408354
[TBL] [Abstract][Full Text] [Related]
10. Highly selective action of triphosphate metabolite of 4'-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT.
Yang G; Dutschman GE; Wang CJ; Tanaka H; Baba M; Anderson KS; Cheng YC
Antiviral Res; 2007 Mar; 73(3):185-91. PubMed ID: 17109975
[TBL] [Abstract][Full Text] [Related]
11. Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases.
Loya S; Rudi A; Kashman Y; Hizi A
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):85-92. PubMed ID: 10548537
[TBL] [Abstract][Full Text] [Related]
12. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities.
Vernekar SK; Liu Z; Nagy E; Miller L; Kirby KA; Wilson DJ; Kankanala J; Sarafianos SG; Parniak MA; Wang Z
J Med Chem; 2015 Jan; 58(2):651-64. PubMed ID: 25522204
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of reverse transcriptase and Taq DNA polymerase by compounds possessing the coumarin framework.
Garro Hugo A; Manzur Jimena M; Ciuffo Gladys M; Tonn Carlos E; Pungitore Carlos R
Bioorg Med Chem Lett; 2014 Feb; 24(3):760-4. PubMed ID: 24418776
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy targeting viral polymerase.
Tsai CH; Lee PY; Stollar V; Li ML
Curr Pharm Des; 2006; 12(11):1339-55. PubMed ID: 16611119
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.
Chen R; Yokoyama M; Sato H; Reilly C; Mansky LM
J Virol; 2005 Sep; 79(18):12045-57. PubMed ID: 16140780
[TBL] [Abstract][Full Text] [Related]
18. Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase.
D'Cruz OJ; Uckun FM
J Enzyme Inhib Med Chem; 2006 Aug; 21(4):329-50. PubMed ID: 17059165
[TBL] [Abstract][Full Text] [Related]
19. Plant Coumarins with Anti-HIV Activity: Isolation and Mechanisms of Action.
Sharapov AD; Fatykhov RF; Khalymbadzha IA; Zyryanov GV; Chupakhin ON; Tsurkan MV
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769163
[TBL] [Abstract][Full Text] [Related]
20. Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ.
Sohl CD; Szymanski MR; Mislak AC; Shumate CK; Amiralaei S; Schinazi RF; Anderson KS; Yin YW
Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8596-601. PubMed ID: 26124101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
